194 related articles for article (PubMed ID: 27570805)
21. How Might Bromodomain and Extra-Terminal (BET) Inhibitors Operate in Cardiovascular Disease?
Schooling CM; Zhao JV
Am J Cardiovasc Drugs; 2019 Apr; 19(2):107-111. PubMed ID: 30693439
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic Modulation by Apabetalone Counters Cytokine-Driven Acute Phase Response
Wasiak S; Gilham D; Daze E; Tsujikawa LM; Halliday C; Stotz SC; Rakai BD; Fu L; Jahagirdar R; Sweeney M; Johansson JO; Wong NCW; Kulikowski E
Cardiovasc Ther; 2020; 2020():9397109. PubMed ID: 32821285
[TBL] [Abstract][Full Text] [Related]
23. Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond.
Di Bartolo BA; Scherer DJ; Nicholls SJ
Arch Med Sci; 2016 Dec; 12(6):1302-1307. PubMed ID: 27904522
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of Hepatic Apolipoprotein A-I Production by Novel Thieno-Triazolodiazepines: Roles of the Classical Benzodiazepine Receptor, PAF Receptor, and Bromodomain Binding.
Kempen HJ; Bellus D; Fedorov O; Nicklisch S; Filippakopoulos P; Picaud S; Knapp S
Lipid Insights; 2013; 6():47-54. PubMed ID: 25278768
[TBL] [Abstract][Full Text] [Related]
25. RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain.
Picaud S; Wells C; Felletar I; Brotherton D; Martin S; Savitsky P; Diez-Dacal B; Philpott M; Bountra C; Lingard H; Fedorov O; Müller S; Brennan PE; Knapp S; Filippakopoulos P
Proc Natl Acad Sci U S A; 2013 Dec; 110(49):19754-9. PubMed ID: 24248379
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Bromodomain and Extra-Terminal Inhibitor Apabetalone on Attenuated Coronary Atherosclerotic Plaque: Insights from the ASSURE Trial.
Shishikura D; Kataoka Y; Honda S; Takata K; Kim SW; Andrews J; Psaltis PJ; Sweeney M; Kulikowski E; Johansson J; Wong NCW; Nicholls SJ
Am J Cardiovasc Drugs; 2019 Feb; 19(1):49-57. PubMed ID: 30155718
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of a novel oral inducer of apolipoprotein a-I synthesis in statin-treated patients with stable coronary artery disease a randomized controlled trial.
Nicholls SJ; Gordon A; Johansson J; Wolski K; Ballantyne CM; Kastelein JJ; Taylor A; Borgman M; Nissen SE
J Am Coll Cardiol; 2011 Mar; 57(9):1111-9. PubMed ID: 21255957
[TBL] [Abstract][Full Text] [Related]
28. Selective inhibition mechanism of RVX-208 to the second bromodomain of bromo and extraterminal proteins: insight from microsecond molecular dynamics simulations.
Wang Q; Li Y; Xu J; Wang Y; Leung EL; Liu L; Yao X
Sci Rep; 2017 Aug; 7(1):8857. PubMed ID: 28821780
[TBL] [Abstract][Full Text] [Related]
29. The BET bromodomain inhibitor apabetalone induces apoptosis of latent HIV-1 reservoir cells following viral reactivation.
Zhang XX; Lin J; Liang TZ; Duan H; Tan XH; Xi BM; Li L; Liu SW
Acta Pharmacol Sin; 2019 Jan; 40(1):98-110. PubMed ID: 29789664
[TBL] [Abstract][Full Text] [Related]
30. ApoA-I induction as a potential cardioprotective strategy: rationale for the SUSTAIN and ASSURE studies.
Nicholls SJ; Gordon A; Johannson J; Ballantyne CM; Barter PJ; Brewer HB; Kastelein JJ; Wong NC; Borgman MR; Nissen SE
Cardiovasc Drugs Ther; 2012 Apr; 26(2):181-7. PubMed ID: 22349989
[TBL] [Abstract][Full Text] [Related]
31. Apabetalone - BET protein inhibition in cardiovascular disease and Type 2 diabetes.
Brandts J; Ray KK
Future Cardiol; 2020 Sep; 16(5):385-395. PubMed ID: 32378426
[TBL] [Abstract][Full Text] [Related]
32. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
[TBL] [Abstract][Full Text] [Related]
33. Apabetalone downregulates factors and pathways associated with vascular calcification.
Gilham D; Tsujikawa LM; Sarsons CD; Halliday C; Wasiak S; Stotz SC; Jahagirdar R; Sweeney M; Johansson JO; Wong NCW; Kalantar-Zadeh K; Kulikowski E
Atherosclerosis; 2019 Jan; 280():75-84. PubMed ID: 30476723
[TBL] [Abstract][Full Text] [Related]
34. Targeting epigenetics as atherosclerosis treatment: an updated view.
Neele AE; Willemsen L; Chen HJ; Dzobo KE; de Winther MPJ
Curr Opin Lipidol; 2020 Dec; 31(6):324-330. PubMed ID: 33027226
[TBL] [Abstract][Full Text] [Related]
35. Domain-selective BET inhibition attenuates transcriptional and behavioral responses to cocaine.
Singh MB; Babigian CJ; Sartor GC
Neuropharmacology; 2022 Jun; 210():109040. PubMed ID: 35314160
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the acetyl lysine-binding pocket of bromodomain and extraterminal domain proteins interferes with adipogenesis.
Goupille O; Penglong T; Kadri Z; Granger-Locatelli M; Fucharoen S; Maouche-Chrétien L; Prost S; Leboulch P; Chrétien S
Biochem Biophys Res Commun; 2016 Apr; 472(4):624-30. PubMed ID: 26972250
[TBL] [Abstract][Full Text] [Related]
37. Bromodomain and Extraterminal (BET) Proteins Regulate Hepatocyte Proliferation in Hepatocyte-Driven Liver Regeneration.
Russell JO; Ko S; Saggi HS; Singh S; Poddar M; Shin D; Monga SP
Am J Pathol; 2018 Jun; 188(6):1389-1405. PubMed ID: 29545201
[TBL] [Abstract][Full Text] [Related]
38. RVX-208, a stimulator of apolipoprotein AI gene expression for the treatment of cardiovascular diseases.
McNeill E
Curr Opin Investig Drugs; 2010 Mar; 11(3):357-64. PubMed ID: 20178050
[TBL] [Abstract][Full Text] [Related]
39. The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation
Wasiak S; Fu L; Daze E; Gilham D; Rakai BD; Stotz SC; Tsujikawa LM; Sarsons CD; Studer D; Rinker KD; Jahagirdar R; Wong NCW; Sweeney M; Johansson JO; Kulikowski E
Transl Neurosci; 2023 Jan; 14(1):20220332. PubMed ID: 38222824
[TBL] [Abstract][Full Text] [Related]
40. Link Between ER-Stress, PPAR-Alpha Activation, and BET Inhibition in Relation to Apolipoprotein A-I Transcription in HepG2 Cells.
van der Krieken SE; Popeijus HE; Mensink RP; Plat J
J Cell Biochem; 2017 Aug; 118(8):2161-2167. PubMed ID: 28012209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
